Form 4: ALX Oncology CFO Peter Garcia Buys 12,000 Shares of ALXO
SEC Form 4
Peter Garcia, CFO of ALX Oncology Holdings Inc, recently purchased 12,000 shares of ALXO common stock at an average price of $8.5282.
Summary
- On June 13, 2024, Peter Garcia, the Chief Financial Officer of ALX Oncology Holdings Inc. (ALXO), purchased 12,000 shares of the company's common stock.
- The shares were bought at a weighted average price of $8.5282, with individual transactions ranging from $8.4113 to $8.68 per share.
- Following this transaction, Garcia directly owns 122,348 shares of ALX Oncology Holdings Inc.
Sentiment
Score: 6
Explanation: Neutral sentiment. The document simply reports an insider stock purchase, which can be seen as mildly positive but doesn't provide enough information to strongly influence sentiment.
Positives
- The CFO's purchase of company stock could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive signal, suggesting that a company insider believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- Shareholders may view the CFO's stock purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of stock purchase transaction. |
| 06/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.